Rexahn files $100 million shelf covering stock, debt and preferreds

By Devika Patel

Knoxville, Tenn., June 22 - Rexahn Pharmaceuticals, Inc. filed a $100 million shelf registration in an S-3 filing with the Securities and Exchange Commission.

The registration covers common stock, preferred stock, warrants, debt securities and units.

The securities may be structured as convertibles.

Proceeds will be used to develop product candidates, for clinical trials, working capital and general corporate purposes.

Rexahn is a biopharmaceutical company based in Rockville, Md.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.